+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Venlafaxine"

CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 898 Pages
  • Global
From
Global Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Global Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 120 Pages
  • Global
From
Treatment Resistant Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cataplexy - Pipeline Insight, 2024 - Product Thumbnail Image

Cataplexy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • August 2023
  • 133 Pages
  • Global
From
Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 190 Pages
  • Global
From
Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • November 2023
  • 231 Pages
  • Global
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Treatment- Resistant Depression Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Treatment- Resistant Depression Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 117 Pages
  • Global
From
Research Report on China's Venlafaxine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Venlafaxine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
Fetzima (levomilnacipran; Allergan) Drug Overview 2019 - Product Thumbnail Image

Fetzima (levomilnacipran; Allergan) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030 - Product Thumbnail Image

Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030

  • Drug Pipelines
  • February 2022
  • 60 Pages
  • Global
From
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • August 2022
  • 170 Pages
  • Global
From
Migraine in America 2023: Key Insights into Treatment Awareness & Satisfaction - Product Thumbnail Image

Migraine in America 2023: Key Insights into Treatment Awareness & Satisfaction

  • Report
  • April 2023
  • 95 Pages
  • Global
Global and Chinese Venlafaxine Hcl Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Venlafaxine Hcl Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 144 Pages
  • China, Global
From
Seasonal Affective Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Seasonal Affective Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 87 Pages
  • Global
From
Venlafaxine (CAS 93413-69-5) Global Market Research Report 2024 - Product Thumbnail Image

Venlafaxine (CAS 93413-69-5) Global Market Research Report 2024

  • Report
  • May 2024
  • 50 Pages
  • Global
From
Loading Indicator

Venlafaxine is a medication used to treat depression, anxiety, and panic disorder. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is classified as a Central Nervous System (CNS) drug. Venlafaxine works by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce anxiety. It is available in both immediate-release and extended-release formulations. Common side effects include nausea, headache, insomnia, and dry mouth. Venlafaxine is a widely prescribed medication and is available in generic form. It is marketed by several pharmaceutical companies, including Pfizer, GlaxoSmithKline, and Mylan. It is also available in combination with other medications, such as bupropion and olanzapine. Venlafaxine is available in both brand-name and generic forms, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. Show Less Read more